NMPA Approval

Voriconazole for Oral Suspension

Approval Number

国药准字H20253658

Company石家庄四药有限公司

Registration Date

March 18, 2025

Drug Information

Generic Name

伏立康唑干混悬剂

Dosage Form

口服混悬剂

Strength

45g：3g，配制成混悬液后伏立康唑浓度为40mg/ml

Drug Type

化学药品

Registration Date

March 18, 2025

Company Information

Applicant Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

Manufacturing Company

Company Name石家庄四药有限公司

Company Address

石家庄高新技术产业开发区槐安东路518号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

伏立康唑干混悬剂 - NMPA 批准文号 | MedPath